| Study on the Mutation of F Gene in 31 Patients with Type B Hemophilia. | Study on the Mutation of FⅨ Gene in 31 Patients with Type B Hemophilia.
Liu D, Guo R, Chen M, Shi B, Weng J, Fu Z., Free PMC Article | 09/25/2024 |
| Crippling down factor IX for therapeutic gain. | Crippling down factor IX for therapeutic gain.
Strijbis VJF, Vatandoost J, Bos MHA. | 12/15/2023 |
| Factor IXa variants resistant to plasma inhibitors enhance clot formation in vivo. | Factor IXa variants resistant to plasma inhibitors enhance clot formation in vivo.
Ivanciu L, Arruda VR, Camire RM., Free PMC Article | 08/11/2023 |
| Whole F9 gene sequencing identified deep intronic variations in genetically unresolved hemophilia B patients. | Whole F9 gene sequencing identified deep intronic variations in genetically unresolved hemophilia B patients.
Dericquebourg A, Fretigny M, Chatron N, Tardy B, Zawadzki C, Chambost H, Vinciguerra C, Jourdy Y. | 08/7/2023 |
| Structural and functional exploration of three newly identified coagulation factor IX mutations in Chinese hemophilia B patients. | Structural and functional exploration of three newly identified coagulation factor IX mutations in Chinese hemophilia B patients.
Wang R, Jiang S, Wang X, Wei D, Xu Q, Wu W. | 07/24/2023 |
| An updated interactive database for 1692 genetic variants in coagulation factor IX provides detailed insights into hemophilia B. | An updated interactive database for 1692 genetic variants in coagulation factor IX provides detailed insights into hemophilia B.
Xu Z, Spencer HJ, Harris VA, Perkins SJ. | 05/4/2023 |
| Liver-heart cross-talk mediated by coagulation factor XI protects against heart failure. | Liver-heart cross-talk mediated by coagulation factor XI protects against heart failure.
Cao Y, Wang Y, Zhou Z, Pan C, Jiang L, Zhou Z, Meng Y, Charugundla S, Li T, Allayee H, Seldin MM, Lusis AJ., Free PMC Article | 10/8/2022 |
| Platelet Activation via Glycoprotein VI Initiates Thrombin Generation: A Potential Role for Platelet-Derived Factor IX? | Platelet Activation via Glycoprotein VI Initiates Thrombin Generation: A Potential Role for Platelet-Derived Factor IX?
Li L, Roest M, Meijers JCM, de Laat B, Urbanus RT, de Groot PG, Huskens D. | 09/3/2022 |
| [Analysis of hereditary coagulation factor deficiency in a Chinese pedigree with compound heterozygous mutations]. | [Analysis of hereditary coagulation factor Ⅺ deficiency in a Chinese pedigree with compound heterozygous mutations].
Deng Y, Gong Y, Zhu J, Zhou X, Wang M, Wu W. | 07/16/2022 |
| Effects of 14 F9 synonymous codon variants on hemophilia B expression: Alteration of splicing along with protein expression. | Effects of 14 F9 synonymous codon variants on hemophilia B expression: Alteration of splicing along with protein expression.
Zhang H, Chen C, Wu X, Lou C, Liang Q, Wu W, Wang X, Ding Q. | 06/18/2022 |
| Active factor XI is associated with the risk of cardiovascular events in stable coronary artery disease patients. | Active factor XI is associated with the risk of cardiovascular events in stable coronary artery disease patients.
Paszek E, Pociask E, Ząbczyk M, Piórkowski A, Butenas S, Legutko J, Undas A. | 05/7/2022 |
| The Molecular Basis of FIX Deficiency in Hemophilia B. | The Molecular Basis of FIX Deficiency in Hemophilia B.
Shen G, Gao M, Cao Q, Li W., Free PMC Article | 04/16/2022 |
| Genome wide CRISPR/Cas9 screen identifies the coagulation factor IX (F9) as a regulator of senescence. | Genome wide CRISPR/Cas9 screen identifies the coagulation factor IX (F9) as a regulator of senescence.
Carpintero-Fernández P, Borghesan M, Eleftheriadou O, Pan-Castillo B, Fafián-Labora JA, Mitchell TP, Yuste A, Ogrunc M, Nightingale TD, Mayan M, O'Loghlen A., Free PMC Article | 04/16/2022 |
| F9 missense mutations impairing factor IX activation are associated with pleiotropic plasma phenotypes. | F9 missense mutations impairing factor IX activation are associated with pleiotropic plasma phenotypes.
Branchini A, Morfini M, Lunghi B, Belvini D, Radossi P, Bury L, Serino ML, Giordano P, Cultrera D, Molinari AC, Napolitano M, Bigagli E, Castaman G, Pinotti M, Bernardi F, GePKHIS Study Group of AICE., Free PMC Article | 03/12/2022 |
| Molecular analysis of severe hemophilia B in Indian families: Identification of mutational hotspot and novel variants. | Molecular analysis of severe hemophilia B in Indian families: Identification of mutational hotspot and novel variants.
Agrawal N, Kumar R, Masih S, Srivastava P, Singh P, Jaiswal SK, Moirangthem A, Saxena D, Phadke SR, Mandal K. | 02/5/2022 |
| X Chromosome inactivation: a modifier of factor VIII and IX plasma levels and bleeding phenotype in Haemophilia carriers. | X Chromosome inactivation: a modifier of factor VIII and IX plasma levels and bleeding phenotype in Haemophilia carriers.
Garagiola I, Mortarino M, Siboni SM, Boscarino M, Mancuso ME, Biganzoli M, Santagostino E, Peyvandi F., Free PMC Article | 01/22/2022 |
| Human coagulation factor IX: a systematic review of its characteristics. | Human coagulation factor IX: a systematic review of its characteristics.
Yin R, Liu C. | 01/15/2022 |
| Sensitivity analysis of a reduced model of thrombosis under flow: Roles of Factor IX, Factor XI, and gamma'-Fibrin. | Sensitivity analysis of a reduced model of thrombosis under flow: Roles of Factor IX, Factor XI, and γ'-Fibrin.
Chen J, Diamond SL., Free PMC Article | 01/8/2022 |
| Inherent hepatocytic heterogeneity determines expression and retention of edited F9 alleles post-AAV/CRISPR infusion. | Inherent hepatocytic heterogeneity determines expression and retention of edited F9 alleles post-AAV/CRISPR infusion.
Wang Q, Zhang L, Zhang GW, Mao JH, Xi XD, Jiang L, Lv G, Lu J, Shen Y, Chen Z, Zhu J, Chen SJ., Free PMC Article | 12/25/2021 |
| Factor IX p.A37V mutation causes severe bleeding in a patient with phenprocoumon therapy. | Factor IX p.A37V mutation causes severe bleeding in a patient with phenprocoumon therapy.
Mülling N, Rosery V, Reinhardt HC, Hanoun M., Free PMC Article | 12/18/2021 |
| Novel F8 and F9 gene variants from the PedNet hemophilia registry classified according to ACMG/AMP guidelines. | Novel F8 and F9 gene variants from the PedNet hemophilia registry classified according to ACMG/AMP guidelines.
Andersson NG, Labarque V, Letelier A, Mancuso ME, Bührlen M, Fischer K, Kartal-Kaess M, Koskenvuo M, Mikkelsen T, Ljung R, PedNet study group., Free PMC Article | 11/27/2021 |
| Abnormal bleeding phenotype for mild haemophilia B patients with the p.Ile112Thr variation on the gene for factor IX. | Abnormal bleeding phenotype for mild haemophilia B patients with the p.Ile112Thr variation on the gene for factor IX.
Row C, Chamouni P, Berger C, Lienhart A, Meunier S, Fretigny M, Dalibard V, Viprey M, Chambost H, Barbay V, Bovet J. | 10/2/2021 |
| Evaluating the potential benefits of the extravascular pool of factor IX. | Evaluating the potential benefits of the extravascular pool of factor IX.
Lillicrap D., Free PMC Article | 08/7/2021 |
| Characterization of missense mutations in the signal peptide and propeptide of FIX in hemophilia B by a cell-based assay. | Characterization of missense mutations in the signal peptide and propeptide of FIX in hemophilia B by a cell-based assay.
Gao W, Xu Y, Liu H, Gao M, Cao Q, Wang Y, Cui L, Huang R, Shen Y, Li S, Yang H, Chen Y, Li C, Yu H, Li W, Shen G., Free PMC Article | 06/19/2021 |
| Identification of novel glycosylation events on human serum-derived factor IX. | Identification of novel glycosylation events on human serum-derived factor IX.
Pegg CL, Zacchi LF, Recinos DR, Howard CB, Schulz BL. | 06/12/2021 |